TVGN EBITDA
-$20.95MTTM · USD
Period ending:
TVGN FY EBITDAUSD
$4.64M-$58.89M
2021-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
TVGN ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 5 observations from Dec 31, 2021 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| -25,570,617 | |
| -13,139,762 | |
| -58,892,971 | |
| 4,639,184 | |
| -14,988,919 |
Compare ebitda
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) ebitda
- Bridgebio Pharma Inc (BBIO) ebitda
- Brightspring Health Services Inc (BTSG) ebitda
- Madrigal Pharmaceuticals Inc (MDGL) ebitda
- Ensign Group Inc (ENSG) ebitda
- Glaukos Corp (GKOS) ebitda
- Vaxcyte Inc (PCVX) ebitda
- Krystal Biotech Inc (KRYS) ebitda
All TVGN financial metrics · TVGN stock overview · How to interpret financial metrics
